Literature DB >> 17950369

Therapeutic myocardial angiogenesis.

Marie-Ange Renault1, Douglas W Losordo.   

Abstract

Armed with an improved understanding of the mediators of angiogenesis, physicians and scientists have made significant efforts at harnessing this naturally occurring process in order to treat patients with a variety of peripheral vascular and coronary ischemic syndromes. There is a growing population of patients with end-stage coronary artery disease (CAD) who are no longer candidates for mechanical revascularization, yet suffer from chronic myocardial ischemia who may benefit from regeneration of the depleted microvasculature.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17950369      PMCID： PMC2172411          DOI： 10.1016/j.mvr.2007.08.005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN： 0026-2862            Impact factor:   3.514


  136 in total

1.  Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha.

Authors:  Kasra Azarnoush; Agnès Maurel; Laurent Sebbah; Claire Carrion; Alvine Bissery; Chantal Mandet; Julia Pouly; Patrick Bruneval; Albert A Hagège; Philippe Menasché
Journal:  J Thorac Cardiovasc Surg       Date:  2005-07       Impact factor: 5.209

2.  Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Authors:  T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; D W Losordo; R C Hendel; R O Bonow; S M Eppler; T F Zioncheck; E B Holmgren; E R McCluskey
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

3.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

5.  Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.

Authors:  E F Unger; L Goncalves; S E Epstein; E Y Chew; C B Trapnell; R O Cannon; A A Quyyumi
Journal:  Am J Cardiol       Date:  2000-06-15       Impact factor: 2.778

6.  VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.

Authors:  M D Hariawala; J R Horowitz; D Esakof; D D Sheriff; D H Walter; B Keyt; J M Isner; J F Symes
Journal:  J Surg Res       Date:  1996-06       Impact factor: 2.192

7.  Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

Authors:  M A Goldberg; T J Schneider
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

8.  Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study.

Authors:  Juan C Chachques; Fabricio Duarte; Barbara Cattadori; Abdel Shafy; Nermine Lila; Gilles Chatellier; Jean-Noel Fabiani; Alain F Carpentier
Journal:  J Thorac Cardiovasc Surg       Date:  2004-08       Impact factor: 5.209

9.  Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

Authors:  Douglas W Losordo; Richard A Schatz; Christopher J White; James E Udelson; Vimal Veereshwarayya; Michelle Durgin; Kian Keong Poh; Robert Weinstein; Marianne Kearney; Muqtada Chaudhry; Aaron Burg; Liz Eaton; Lindsay Heyd; Tina Thorne; Leon Shturman; Peter Hoffmeister; Ken Story; Victor Zak; Douglas Dowling; Jay H Traverse; Rachel E Olson; Janice Flanagan; Donata Sodano; Toshinori Murayama; Atsuhiko Kawamoto; Kengo Fukushima Kusano; Jill Wollins; Frederick Welt; Pinak Shah; Peter Soukas; Takayuki Asahara; Timothy D Henry
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  20 in total

Review 1.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

2.  Angiogenic potential of microvessel fragments is independent of the tissue of origin and can be influenced by the cellular composition of the implants.

Authors:  Sara S Nunes; Laxminarayanan Krishnan; Carter S Gerard; Jacob R Dale; Melissa A Maddie; Richard L Benton; James B Hoying
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

3.  An inconvenient truth: recognizing individual differences in arteriogenesis.

Authors:  Jalees Rehman
Journal:  Circ Res       Date:  2008-05-23       Impact factor: 17.367

4.  How Can We Cheat Arterial Atherosclerosis?

Authors:  Mircea Cinteza
Journal:  Maedica (Buchar)       Date:  2016-06

Review 5.  Focal adhesion kinase regulation of neovascularization.

Authors:  Kishore K Wary; Erin E Kohler; Ishita Chatterjee
Journal:  Microvasc Res       Date:  2011-05-14       Impact factor: 3.514

6.  Bioengineering the infarcted heart by applying bio-inspired materials.

Authors:  Emil Ruvinov; Tamar Harel-Adar; Smadar Cohen
Journal:  J Cardiovasc Transl Res       Date:  2011-06-08       Impact factor: 4.132

Review 7.  Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

Authors:  James W Yockman; Andrew Kastenmeier; Harold M Erickson; Jonathan G Brumbach; Matthew G Whitten; Aida Albanil; Dean Y Li; Sung Wan Kim; David A Bull
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

Review 8.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

9.  The neovascularization effect of bone marrow stromal cells in temporal muscle after encephalomyosynangiosis in chronic cerebral ischemic rats.

Authors:  Hyung-Syup Kim; Hyung-Jin Lee; In-Seung Yeu; Jin-Seok Yi; Ji-Ho Yang; Il-Woo Lee
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

Review 10.  Update on therapeutic vascularization strategies.

Authors:  Edward A Phelps; Andres J Garcia
Journal:  Regen Med       Date:  2009-01       Impact factor: 3.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.